×
About 29,280 results

ALLMedicine™ Constipation Center

Research & Reviews  9,883 results

Editorial Comment to Presence of constipation predicts the therapeutic efficacy of pemb...
https://doi.org/10.1111/iju.14379
International Journal of Urology : Official Journal of the Japanese Urological Association References; Yuasa T

Sep 17th, 2020 - Editorial Comment to Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastatic urothelial cancer patients.|2020|Yuasa T,|

Role of transverse diameter of the rectum in lower urinary tract symptoms and functiona...
https://doi.org/10.1111/jpc.15155
Journal of Paediatrics and Child Health References; de Abreu GE, de Souza LA et. al.

Sep 15th, 2020 - Although a correlation has been reported between enlarged rectal diameter and functional constipation (FC), the relevance of measuring the transverse diameter of the rectum for diagnosing FC remains unclear, even in patients with lower urinary tra...

Metabolomics study on the therapeutic effect of the Chinese herb pair Fructus Aurantii ...
https://doi.org/10.21037/apm-20-280
Annals of Palliative Medicine; Yan S, Hao M et. al.

Sep 14th, 2020 - In China, Zhishi (Aurantii Fructus Immaturus) - Baizhu (Atractylodis Macrocephalae Rhizoma) is a well-known herb pair used to treat gastrointestinal motility disorders for thousands of years, and it has especially shown a definite advantage in the...

Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastat...
https://doi.org/10.1111/iju.14367
International Journal of Urology : Official Journal of the Japanese Urological Association References; Inoue S, Sassa N et. al.

Sep 14th, 2020 - To study bowel function in urothelial cancer patients treated with pembrolizumab and to assess its association with treatment efficacy. This retrospective study was analyzed for patients with metastatic urothelial cancer who received immune checkp...

A Case of Resolved Vincristine-Induced Constipation Following Osteopathic Medicine in a...
https://doi.org/10.7556/jaoa.2020.102
The Journal of the American Osteopathic Association; Belsky JA, Wolf K et. al.

Sep 14th, 2020 - Vincristine-induced constipation is a common side effect in pediatric oncology patients. We report the case of an infant with histologic diagnosis of infantile fibrosarcoma who developed significant constipation because of ongoing vincristine admi...

see more →

Guidelines  67 results

Update on the Management of Constipation
https://jamanetwork.com/journals/jama/article-abstract/2754106
JAMA Wald A

Nov 16th, 2019 - Chronic constipation is very common. The most recent estimate of clinician visits attributable to constipation were from 2001 to 2004 and reported more than 8 million clinician visits in the United States, with most occurring in adult primary care...

Chronic Constipation: New Insights, Better Outcomes?
https://www.ncbi.nlm.nih.gov/pubmed/31609241
Lancet Gastroenterology Hepatology; Schiller LR

Oct 31st, 2019 - Constipation is a symptom that affects around 11-20% of the adult population yearly. Most physicians consider infrequency of defecation as a hallmark of constipation. However, most patients view excessive straining as the biggest component of cons...

A Comparison of the Efficacy of Enema Solutions in Pediatric Emergency Department Patients
https://www.ncbi.nlm.nih.gov/pubmed/31594739
Journal of Emergency Medicine; Anderson J,et al

Oct 4th, 2019 - Children presenting to pediatric emergency departments (EDs) are frequently given enemas for relief of constipation symptoms; there is very little literature guiding solution selection.

Ardelyx Receives FDA Approval For Ibsrela® (Tenapanor), An NHE3 Sodium Transport Inhibitor, For The Treatment Of Irritable Bowel Syndrome With Constipation
http://ir.ardelyx.com/news-releases/news-release-details/ardelyx-receives-fda-approval-ibsrelar-tenapanor-nhe3-sodium

Sep 10th, 2019 - Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today announced that the U.S. Food and Drug Administration h...

Efficacy of Drugs in Chronic Idiopathic Constipation: a Systematic Review & Network Meta-Analysis
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(19)30246-8/fulltext
The Lancet Gastroenterology & Hepatology; Luthra P,et al

Aug 28th, 2019 - There are several drugs available for the treatment of chronic idiopathic constipation, but their relative efficacy is unclear because there have been no head-to-head randomised controlled trials. We did a network meta-analysis to compare the effi...

see more →

Drugs  4,253 results see all →

Clinicaltrials.gov  14,473 results

Editorial Comment to Presence of constipation predicts the therapeutic efficacy of pemb...
https://doi.org/10.1111/iju.14379
International Journal of Urology : Official Journal of the Japanese Urological Association References; Yuasa T

Sep 17th, 2020 - Editorial Comment to Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastatic urothelial cancer patients.|2020|Yuasa T,|

Stool softner - docusate sodium capsule, liquid filled-NuCare Pharmaceuticals,Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=762ca8a8-37df-56b6-e053-2991aa0a743c

Sep 16th, 2020 - relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hoursStool softener

Milk of magnesia - magnesium hydroxide suspension-Fact Products
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aebbdd10-0650-6efe-e053-2a95a90a0ab2

Sep 16th, 2020 - relieves occasional constipation (irregularity) generally produces bowel movement in 1/2 to 6 hoursSaline laxative

Stool softener plus stimulant laxative - docusate sodium and sennosides tablet-Care One (Retail Business Services, LLC.)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9adaec97-43e3-48f2-96c8-c508b693676c

Sep 16th, 2020 - relieves ccasional constipation (irregularity) generally produces bowel movement in 6 to12 hoursStool softener Stimulant laxative

see more →

News  499 results

FDA strengthens warning regarding clozapine, serious bowel complication risk
https://www.mdedge.com/gihepnews/article/216329/schizophrenia-other-psychotic-disorders/fda-strengthens-warning-regarding?channel=345
Lucas Franki, MDedge News

Jan 28th, 2020 - The Food and Drug Administration is strengthening a previous warning regarding the uncommon risk of serious bowel complications associated with the schizophrenia medication clozapine (Clozaril, FazaClo ODT, Versacloz). Wikimedia Commons/FitzColinG.

Clozaril, Fazaclo ODT, Versacloz (clozapine): Drug Safety Communication - FDA Strengthens Warning That Untreated Constipation Can Lead to Serious Bowel Problems | FDA
https://www.fda.gov/safety/medical-product-safety-information/clozaril-fazaclo-odt-versacloz-clozapine-drug-safety-communication-fda-strengthens-warning-untreated

[Posted: January 28, 2020] AUDIENCE: Patient, Health Professional ISSUE: FDA is strengthening an existing warning that constipation caused by the schizophrenia medicine clozapine (Clozaril, Fazaclo ODT, Versacloz, generics) can, uncommonly, progre...

Is elagolix effective at reducing HMB for women with varying fibroid sizes and types?
https://www.mdedge.com/obgyn/article/215165/endometriosis/elagolix-effective-reducing-hmb-women-varying-fibroid-sizes-and?channel=218
Lila O'Connor, Editor

Jan 8th, 2020 - Whether or not women experience symptoms from uterine fibroid(s) can be dependent on a fibroid’s size and location. Heavy menstrual bleeding (HMB) is the most common symptom resulting from fibroids, and it occurs in up to one-third of women with f.

What do the new AGA guidelines recommend for opioid-induced constipation?
https://www.mdedge.com/clinicianreviews/article/214590/gastroenterology/what-do-new-aga-guidelines-recommend-opioid-induced?channel=213
Doug Campos-Outcalt, MD, MPA

Dec 19th, 2019 - References Crockett SD, Greer KB, Heidelbaugh JJ, et al. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation.

Biofeedback corrects dyssynergic constipation in elderly
https://www.mdedge.com/gihepnews/article/214559/gastroenterology/biofeedback-corrects-dyssynergic-constipation-elderly?channel=53
Bruce Jancin, MDedge News

Dec 19th, 2019 - SAN ANTONIO – Biofeedback for treatment of dyssynergic constipation is highly effective in the elderly, just as it is in younger patients, Samantha Spilman, MD, reported at the annual meeting of the American College of Gastroenterology. Bruce Janc.

see more →

Patient Education  105 results see all →